-
Liquid Biopsy Tech Adapted for Covid-19 Testing
A company developing non-invasive liquid biopsy tests for cancer received NIH funding to extend that technology for quick Covid-19 virus tests.
-
Biotechs Partner on Synthetic Plant-Based Drugs
Two biotechnology companies are designing new processes to produce ingredients much like those found in drugs made from plants for essential medicines.
-
RNA Manufacturer Goes Public in $282M Merger
A company producing synthetic RNA for agricultural and biomedical applications is now a public company after a special-purpose acquisition.
-
Moderna to Build mRNA Vaccine Plant in Canada
The biotechnology company Moderna Inc. agreed to build a manufacturing plant for its messenger RNA or mRNA vaccines in Canada.
-
Gates Grant Funds HIV-Birth Control Implant
A biotechnology company received a foundation grant for an implanted device to prevent HIV infection and unwanted pregnancy in women.
-
Infographic – Biomedical Innovation Gains Continue
Two statistical indicators provide more evidence that innovations in health and medicine are continuing their sharp upward climb.
-
Portable Testing Device IDs Covid-19 Variants
A low-cost device is being developed that analyzes saliva samples for SARS-CoV-2 viral mutations, and returns results in about one hour.
-
Protein Chemistry Biotech Acquired in $2B Deal
Drug maker Bayer is acquiring a company discovering new therapies with a technology that reveals complex protein targets considered difficult to address.
-
Tech Shaping the Post-Covid Healthcare Landscape
Tech adopted during the pandemic looks set to continue as we transition into a world where the virus doesn’t control us.
-
NIH Funds Programmable mRNA to Treat Cancer
National Cancer Institute is funding research on using programmable synthetic messenger RNA to treat two types of solid tumor cancer.